HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amphotericin B lipid complex for neonatal invasive candidiasis.

Abstract
This study describes the safety and efficacy of amphotericin B lipid complex (ABLC) in 11 neonates with systemic Candida infections. Nine of the 11 improved clinically, and eight of nine evaluable patients had a mycological cure with ABLC. Creatinine levels improved or did not significantly change in eight of the 11 patients.
AuthorsF Adler-Shohet, H Waskin, J M Lieberman
JournalArchives of disease in childhood. Fetal and neonatal edition (Arch Dis Child Fetal Neonatal Ed) Vol. 84 Issue 2 Pg. F131-3 (Mar 2001) ISSN: 1359-2998 [Print] England
PMID11207232 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Drug Combinations
  • Phosphatidylcholines
  • Phosphatidylglycerols
  • liposomal amphotericin B
  • Amphotericin B
  • Creatinine
Topics
  • Amphotericin B (therapeutic use)
  • Antifungal Agents (therapeutic use)
  • Candidiasis (blood, drug therapy)
  • Creatinine (blood)
  • Drug Combinations
  • Humans
  • Infant
  • Infant, Newborn
  • Kidney Function Tests
  • Phosphatidylcholines (therapeutic use)
  • Phosphatidylglycerols (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: